PCM Encore LLC acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 17,958 shares of the company’s stock, valued at approximately $2,308,000.
Other institutional investors also recently bought and sold shares of the company. Frazier Financial Advisors LLC acquired a new position in Merck KGaA in the second quarter valued at approximately $25,000. Addison Advisors LLC purchased a new position in Merck KGaA in the second quarter worth approximately $90,000. Comprehensive Financial Planning Inc. PA acquired a new stake in Merck KGaA during the second quarter worth $134,000. Stevens Capital Partners acquired a new stake in Merck KGaA during the second quarter worth $220,000. Finally, United Bank purchased a new stake in Merck KGaA in the second quarter valued at $248,000. 0.10% of the stock is owned by hedge funds and other institutional investors.
Merck KGaA Stock Performance
Shares of Merck KGaA stock opened at $162.12 on Friday. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The business’s fifty day simple moving average is $162.47 and its 200-day simple moving average is $148.35. The firm has a market cap of $20.95 billion, a PE ratio of 24.75 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
